• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. GYNECARE INTERCEED 5INX6IN; BARRIER, ABSORBABLE, ADHESION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. GYNECARE INTERCEED 5INX6IN; BARRIER, ABSORBABLE, ADHESION Back to Search Results
Catalog Number 4350XL
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abscess (1690); Fever (1858); Pain (1994)
Event Date 08/26/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).To date the device has not been returned.If the device or further details are received at the later date a supplemental medwatch will be sent.Additional information was requested, and the following was obtained: what was indication for the initial surgery? transverse colectomy.Were there any pre-existing signs/symptoms of active infection prior to this surgical procedure? no further information is available.Did the patient receive any prophylactic antibiotics pre- or intra-operation? no further information is available.Does the surgeon believe that interceed is a cause of this event? no further information is available.What is the patient's most current status? the patient is hospitalized as of (b)(6) 2019.No further information will be provided.
 
Event Description
It was reported that the patient underwent a laparoscopic transverse colectomy on (b)(6) 2019 and the absorbable adhesive barrier was placed under the abdominal wall.On (b)(6) 2019, the patient had a fever of 38.8 degrees.There was no abdominal pain, but the patient had a slight pain when the affected site was pushed.On (b)(6) 2019, ct scan was performed, and it was found that abdominal abscess had occurred at the part where the absorbable adhesive barrier had been placed.Drainage was performed through a small incision, and 200ml of cloudy white liquid, gray slightly mixed with brown, was collected.It was thin like water, and odorless.Crp level was 13.38.Medication of flumarin was administered for gram-positive bacilli.On (b)(6) 2019, crp level was 11.34.The patient¿s fever became to normal, and she recovered enough to drink water through the mouth.On (b)(6) 2019, crp level was 2.4 and the patient recovered enough to eat food.The patient is hospitalized as of (b)(6) 2019.The patient was treated with anti-cancer drugs, and she has already been recovered enough to eat.The patient is recovering smoothly, and no additional treatment is planned.The patient is recovering after the drainage.The surgeon also opined other contributing factor is that during the surgery, the surgeon handled sigmoid colon and cleaning was performed, but there is a possibility that it was not clean enough.No further information is available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GYNECARE INTERCEED 5INX6IN
Type of Device
BARRIER, ABSORBABLE, ADHESION
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
MDR Report Key9114411
MDR Text Key166540844
Report Number2210968-2019-88065
Device Sequence Number1
Product Code MCN
UDI-Device Identifier10705031147843
UDI-Public10705031147843
Combination Product (y/n)N
PMA/PMN Number
P880047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 09/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number4350XL
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/06/2019
Initial Date FDA Received09/25/2019
Supplement Dates Manufacturer Received09/06/2019
Supplement Dates FDA Received09/26/2019
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age90 YR
Patient Weight38
-
-